Class ITerminated in FDA datasetJan 7, 2016

1) COMPOUNDED ASAFOETIDA POWDER L.G.¿, NET WT. 50g (1.75OZ.)

Recalling firm: SHAKTI GROUP USA LLC

Why it was recalled

L.G. compounded Asafoetida powder has the potential to be contaminated with Salmonella.

Check your package

Compare the exact product and package details with the label you have.

Product1) COMPOUNDED ASAFOETIDA POWDER L.G.¿, NET WT. 50g (1.75OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot No. 53/4, Road 7/15, M.I.D.C.,Andheri (E). Mumbai - 400 093. (INDIA) Lot No., Pkd & Best Before See Bottom LOT NO. 2323" 2) COMPOUNDED ASAFOETIDA POWDER L.G¿, NET WT. 100g (3.5OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot No. 53/4, Road 7/15, M.I.D.C., Andheri (E). Mumbai - 400 093. (INDIA) Lot No., Pkd & Best Before See Bottom LOT NO. 2323"

FDA code information

Lot 2323

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

1) COMPOUNDED ASAFOETIDA POWDER L.G.¿, NET WT. 50g (1.75OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot No. 53/4, Road 7/15, M.I.D.C.,Andheri (E). Mumbai - 400 093. (INDIA) Lot No., Pkd & Best Before See Bottom LOT NO. 2323" 2) COMPOUNDED ASAFOETIDA POWDER L.G¿, NET WT. 100g (3.5OZ.), MANUFACTURED BY: LALJEE GODHOO & CO. 213, Samuel Street, Mumbai - 400 003, (INDIA) MANUFACTURED AT: LALJEE GODHOO & CO. Plot No. 53/4, Road 7/15, M.I.D.C., Andheri (E). Mumbai - 400 093. (INDIA) Lot No., Pkd & Best Before See Bottom LOT NO. 2323"

Recall details

Recall number
F-1121-2016
Event ID
73020
FDA status
Terminated
Initiated
Jan 7, 2016
Reported
Apr 27, 2016
Classified
Apr 20, 2016
Terminated
Oct 23, 2017
Quantity
approximately 10000 bottles
Location
New Brunswick, NJ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

NH, NJ, PA, OH & VA

FDA source record · F-1121-2016

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.